{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "19916514", "DateCompleted": {"Year": "2010", "Month": "03", "Day": "25"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1021/tx900306p"], "ArticleDate": [], "Journal": {"ISSN": "1520-5010", "JournalIssue": {"Volume": "23", "Issue": "1", "PubDate": {"Year": "2010", "Month": "Jan"}}, "Title": "Chemical research in toxicology", "ISOAbbreviation": "Chem Res Toxicol"}, "ArticleTitle": "Low-concentration ozone reacts with plasmalogen glycerophosphoethanolamine lipids in lung surfactant.", "Pagination": {"StartPage": "108", "EndPage": "117", "MedlinePgn": "108-17"}, "Abstract": {"AbstractText": ["Ozone is a common environmental toxicant to which individuals are exposed to on a daily basis. While biochemical end points such as increased mortality, decrements in pulmonary function, and initiation of inflammatory processes are known, little is actually understood regarding the chemical mechanisms underlying changes in pulmonary health, especially for low concentrations of ozone. This study was undertaken to investigate ozone-induced oxidation of endogenous lipids that are potentially exposed to environmental ozone within lung, specifically focusing on plasmalogen glycerophospholipids present in pulmonary surfactant. Sensitive liquid chromatography-mass spectrometry methods were developed to follow oxidation of diacyl and plasmalogen phosphatidylethanolamine (PE) phospholipids and to identify and quantitate products generated by ozonolysis. Using a unilamellar vesicle system containing a 1:1 molar mixture of 1-O-octadec-1'-enyl-2-octadecenoyl-PE and 1,2-dihexadecanoyl-PC, these studies revealed that the vinyl ether bond of plasmalogens was oxidized preferentially at low concentrations of ozone (100 ppb), when compared to olefinic bond oxidation on omega-9 of the fatty acyl chain in the same phospholipids. Major phospholipid products generated were identified as 1-formyl-2-octadecenoyl-PE and 1-hydroxy-2-octadecenoyl-PE. Heptadecanal and heptadecanoic acid production was also quantitated using gas chromatography-mass spectrometry, and production was consistent with oxidation of the vinyl ether, at low concentrations of ozone. Analysis of murine lung surfactant from C57Bl/6 mice revealed several plasmalogen PE lipid species, encompassing approximately 38% of total PE species. Upon exposure of ozone (0 and 100 ppb) to murine surfactant, plasmalogen PE molecular species preferentially reacted, as compared to diacyl PE molecular species. Lysophospholipids, pentadecanal, and nonanal were found to be the primary products of surfactant ozone oxidation."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, University of Colorado Denver, MS 8303, 12801 E. 17th Ave., Aurora, Colorado 80045, USA."}], "Identifier": [], "LastName": "Wynalda", "ForeName": "Kelly M", "Initials": "KM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Murphy", "ForeName": "Robert C", "Initials": "RC"}], "GrantList": [{"GrantID": "P01 HL034303", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "P01 HL034303-240004", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL034303", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Chem Res Toxicol", "NlmUniqueID": "8807448", "ISSNLinking": "0893-228X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Phosphatidylethanolamines"}, {"RegistryNumber": "0", "NameOfSubstance": "Plasmalogens"}, {"RegistryNumber": "0", "NameOfSubstance": "Pulmonary Surfactants"}, {"RegistryNumber": "0", "NameOfSubstance": "Unilamellar Liposomes"}, {"RegistryNumber": "1190-00-7", "NameOfSubstance": "glycerophosphoethanolamine"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Oxidation-Reduction"}, {"QualifierName": ["chemistry", "toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylethanolamines"}, {"QualifierName": ["metabolism"], "DescriptorName": "Plasmalogens"}, {"QualifierName": ["chemistry"], "DescriptorName": "Pulmonary Surfactants"}, {"QualifierName": [], "DescriptorName": "Spectrometry, Mass, Electrospray Ionization"}, {"QualifierName": ["chemistry"], "DescriptorName": "Unilamellar Liposomes"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ciencewicki J, Trivedi S, Kleeberger SR. Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol. 2008;122:456\u2013468.", "ArticleIdList": ["PMC2693323", "18774381"]}, {"Citation": "Finlayson-Pitts BJ, Pitts JN. Chemistry of the Upper and Lower Atmosphere. San Diego, CA: Academic Press; 2000."}, {"Citation": "Tong DQ, Yu S, Kan H. Ozone exposure and mortality. N.Engl.J.Med. 2009;360:2788\u20132789.", "ArticleIdList": ["19557887"]}, {"Citation": "Michalec L, Choudhury BK, Postlethwait E, Wild JS, Alam R, Lett-Brown M, Sur S. CCL7 and CXCL10 orchestrate oxidative stress-induced neutrophilic lung inflammation. J.Immunol. 2002;168:846\u2013852.", "ArticleIdList": ["11777981"]}, {"Citation": "Bernard A, Carbonnelle S, Nickmilder M, de Burbure C. Non-invasive biomarkers of pulmonary damage and inflammation: Application to children exposed to ozone and trichloramine. Toxicol.Appl.Pharmacol. 2005;206:185\u2013190.", "ArticleIdList": ["15967207"]}, {"Citation": "Brown JS, Bateson Bateson, McDonnell WF. Effects of exposure to 0.06 ppm ozone on FEV1 in humans: a secondary analysis of existing data. Environ.Health perspect. 2008;116:1023\u20131026. 2008.", "ArticleIdList": ["PMC2516571", "18709151"]}, {"Citation": "Schelegle ES, Morales CA, Walby WF, Marion S, Allen RP. 6.6-hour inhalation of ozone concentrations from 60 to 87 parts per billion in healthy humans. Am.J.Respir.Crit Care Med. 2009;180:265\u2013272.", "ArticleIdList": ["19447899"]}, {"Citation": "Hoppe P, Peters A, Rabe G, Praml G, Lindner J, Jakobi G, Fruhmann G, Nowak D. Environmental ozone effects in different population subgroups. Int.J.Hyg.Environ.Health. 2003;206:505\u2013516.", "ArticleIdList": ["14626898"]}, {"Citation": "Devlin RB, McDonnell WF, Mann R, Becker S, House DE, Schreinemachers D, Koren HS. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am.J.Respir.Cell Mol.Biol. 1991;4:72\u201381.", "ArticleIdList": ["1846079"]}, {"Citation": "Thurston GD, Lippmann M, Scott MB, Fine JM. Summertime haze air pollution and children with asthma. Am.J.Respir.Crit Care Med. 1997;155:654\u2013660.", "ArticleIdList": ["9032209"]}, {"Citation": "Pryor WA. How far does ozone penetrate into the pulmonary air/tissue boundary before it reacts? Free Radic.Biol.Med. 1992;12:83\u201388.", "ArticleIdList": ["1537573"]}, {"Citation": "Dahl M, Bauer AK, Arredouani M, Soininen R, Tryggvason K, Kleeberger SR, Kobzik L. Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. J.Clin.Invest. 2007;117:757\u2013764.", "ArticleIdList": ["PMC1804372", "17332894"]}, {"Citation": "Postlethwait EM. Scavenger receptors clear the air. J.Clin.Invest. 2007;117:601\u2013604. 2007.Mar.;117.(3):601.\u20134.", "ArticleIdList": ["PMC1804350", "17332891"]}, {"Citation": "Pulfer MK, Murphy RC. Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant. J.Biol.Chem. 2004;279:26331\u201326338.", "ArticleIdList": ["15096493"]}, {"Citation": "Uhlson C, Harrison K, Allen CB, Ahmad S, White CW, Murphy RC. Oxidized phospholipids derived from ozone-treated lung surfactant extract reduce macrophage and epithelial cell viability. Chem.Res.Toxicol. 2002;15:896\u2013906.", "ArticleIdList": ["12118999"]}, {"Citation": "Stadelmann-Ingrand S, Pontcharraud R, Fauconneau B. Evidence for the reactivity of fatty aldehydes released from oxidized plasmalogens with phosphatidylethanolamine to form Schiff base adducts in rat brain homogenates. Chem.Phys.Lipids. 2004;131:93\u2013105.", "ArticleIdList": ["15210368"]}, {"Citation": "Murphy RC. Free-radical-induced oxidation of arachidonoyl plasmalogen phospholipids: antioxidant mechanism and precursor pathway for bioactive eicosanoids. Chem.Res.Toxicol. 2001;14:463\u2013472.", "ArticleIdList": ["11368542"]}, {"Citation": "Diagne A, Fauvel J, Record M, Chap H, Douste-Blazy L. Studies on ether phospholipids. II. Comparative composition of various tissues from human, rat and guinea pig. Biochim.Biophys.Acta. 1984;793:221\u2013231.", "ArticleIdList": ["6712967"]}, {"Citation": "Zoeller RA, Lake AC, Nagan N, Gaposchkin DP, Legner MA, Lieberthal W. Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether. Biochem.J. 1999;338(Pt 3):769\u2013776.", "ArticleIdList": ["PMC1220115", "10051451"]}, {"Citation": "Engelmann B. Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem.Soc.Trans. 2004;32:147\u2013150.", "ArticleIdList": ["14748736"]}, {"Citation": "Rustow B, Kolleck I, Guthmann F, Haupt R, Kunze D, Stevens P. Sythesis and secretion of plasmalogens by type II pneumocytes. Biochem. J. 1994;302:665\u2013668.", "ArticleIdList": ["PMC1137282", "7945189"]}, {"Citation": "Schmidt R, Luboeinski T, Markart P, Ruppert C, Daum C, Grimminger F, Seeger W, Gunther A. Alveolar antioxidant status in patients with acute respiratory distress syndrome. Eur.Respir.J. 2004;24:994\u2013999.", "ArticleIdList": ["15572544"]}, {"Citation": "Zemski Berry KA, Turner WW, VanNieuwenhze MS, Murphy RC. Stable Isotope Labeled 4-(Dimethylamino)benzoic Acid Derivatives of Glycerophosphoethanolamine Lipids. Analytical Chemistry. 2009 in press.", "ArticleIdList": ["PMC2929906", "20337376"]}, {"Citation": "Notter Robert. Lung Surfactants: Basic Science and Clinical Applications. In: Lenfant C, editor. Lung Biology in Health and Disease. New York: Marcel Dekker; 2000."}, {"Citation": "Kim HY, Salem N., Jr Separation of lipid classes by solid phase extraction. J.Lipid Res. 1990;31:2285\u20132289.", "ArticleIdList": ["2090722"]}, {"Citation": "Zemski Berry KA, Murphy RC. Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids. J.Am.Soc.Mass Spectrom. 2004;15:1499\u20131508.", "ArticleIdList": ["15465363"]}, {"Citation": "Snyder F, Blank ML, Wykle RL. The enzymic synthesis of ethanolamine plasmalogens. J.Biol.Chem. 1971;246:3639\u20133645.", "ArticleIdList": ["4397105"]}, {"Citation": "Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can.J.Biochem.Physiol. 1959;37:911\u2013917.", "ArticleIdList": ["13671378"]}, {"Citation": "Luo XP, Yazdanpanah M, Bhooi N, Lehotay DC. Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Anal.Biochem. 1995;228:294\u2013298.", "ArticleIdList": ["8572309"]}, {"Citation": "Hadley JS, Fradin A, Murphy RC. Electron capture negative ion chemical ionization analysis of arachidonic acid. Biomed.Environ.Mass Spectrom. 1988;15:175\u2013178.", "ArticleIdList": ["3130114"]}, {"Citation": "Clay K. Methods in Enzymology. In: Murphy RC, Fitzpatrick FA, editors. Arachidonate Related Lipid Mediators. San Diego: Academic Press; 1990."}, {"Citation": "Creer MH, Gross RW. Separation of isomeric lysophospholipids by reverse phase HPLC. Lipids. 1985;20:922\u2013928.", "ArticleIdList": ["4094522"]}, {"Citation": "Hurly BP, McCormick BA. Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation. Infection and Immunity. 2008;76(6):2259\u20132272.", "ArticleIdList": ["PMC2423084", "18411286"]}, {"Citation": "De Luca D, Silvia B, Vento G, Piastra M, Pietrini D, Romitelli F, Capoluongo E, Romagnoli C, Conti G, Zecca E. Secretory phospholipases A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage. Intensive Care Med. 2008;34:1858\u20131864.", "ArticleIdList": ["18648767"]}, {"Citation": "Arbibe L, Koumanov K, Vial D, Rougeot C, Faure G, Havet N, Longacre S, Vargaftig BB, Bereziat G, Voelker DR, Wolf C, Touqui L. Generation of Lysophospholipids from Surfactant in Acute Lung Injury is Mediated by Type-II Phospholipase A2 and Inhibited by a Direct Surfactant Protein A-Phospholipase Protein Interaction. J. Clin Invest. 1998;102:1152\u20131160.", "ArticleIdList": ["PMC509098", "9739049"]}, {"Citation": "Grosjean E, Grosjean D. The Reaction of Unsaturated Aliphatic Oxygenates with Ozone. Journal of Atmospheric Chemistry. 1999;32(1):205\u2013232."}, {"Citation": "Grosjean E, Grosjean D. Rate Constants for the Gas Phase Reaction of Ozone with Unsaturated Oxygenates. International Journal of Chemical Kinetics. 1998;30(1):21\u201329."}, {"Citation": "Pryor WA, Giamalva D, Church DF. Kinetics of ozonation. 3. Substituent effects on the rates of reaction of alkenes. Journal of the American Chemical Society. 1985;107:2793\u20132797."}, {"Citation": "Criegee R. Mechanism of Ozonolysis. Angnew Chem Int Ed. 1975;14(11):745\u2013752."}, {"Citation": "Bernhard W, Wand J, Tschernig T, Tummler B, Hedrich HJ, von der Hardt H. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm2HGU/m2HGU mice. Thorax. 1997;52:723\u2013730.", "ArticleIdList": ["PMC1758618", "9337833"]}, {"Citation": "Nakos G, Kitsiouli E, Hatzidaki E, Koulouras V, Touqui L, Lekka M. Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome. Crit Care Med. 2005;33:772\u2013779.", "ArticleIdList": ["15818104"]}, {"Citation": "Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins & other Lipid Mediators. 2002;68\u201369:3\u201358.", "ArticleIdList": ["12432908"]}, {"Citation": "Min J, Wilder C, Aoki J, Arai H, Inoue K, Paul L, Gelb M. Platelet Activating Factor Acetylhydrolases: Broad Substrate Specificity and Lipoprotein Binding Does Not Modulate the Catalytic Properties of the Plasma Enzyme. Biochemistry. 2001;40:4539\u20134549.", "ArticleIdList": ["11294621"]}, {"Citation": "Rudiger M, Kolleck I, Putz G, Wauer RR, Stevens P, Rustow B. Plasmalogens effectively reduce the surface tension of surfactant-like phospholipid mixtures. Am.J.Physiol. 1998;274:L143\u2013L148.", "ArticleIdList": ["9458812"]}, {"Citation": "Rudiger M, von Baehr A, Haupt R, Wauer RR, Rustow B. Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonay dysplasia less ofter. Crit Care Med. 2000;28:1572\u20131577.", "ArticleIdList": ["10834714"]}, {"Citation": "Frasch SC, Zemski-Berry K, Murphy RC, Borregaard N, Henson PM, Bratton DL. Lysophospholipids of different classes mobilize neutrophil secretory vesicles and induce redundant signaling through G2A. J.Immunol. 2007;178:6540\u20136548.", "ArticleIdList": ["17475884"]}, {"Citation": "Gay I, Schwartz Z, Sylvia VL, Boyan BD. Lysophospholipid regulates release and activation of latent TGF-beta1 from chondrocyte extracellular matrix. Biochim.Biophys.Acta. 2004;1684:18\u201328.", "ArticleIdList": ["15450206"]}, {"Citation": "Nishina A, Kimura H, Sekiguchi A, Fukumoto RH, Nakajima S, Furukawa S. Lysophosphatidylethanolamine in Grifola frondosa as a neurotrophic activator via activation of MAPK. J.Lipid Res. 2006;47:1434\u20131443.", "ArticleIdList": ["16614393"]}, {"Citation": "Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, Polosukhin V, Wain J, Karimi-Shah BA, Kim ND, Hart WK, Pardo A, Blackwell TS, Xu Y, Chun J, Luster AD. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nature Med. 2008;14:45\u201354.", "ArticleIdList": ["18066075"]}, {"Citation": "He D, Su Y, Usatyuk PV, Spannhake EW, Kogut P, Solway J, Natarajan V, Zhao Y. Lysophosphatidic Acid Enhances Pulmonary Epithelial Barrier Integrity and Protects Endotoxin-Induced Epithelial Barrier Disruption and Lung Injury. J. Biol. Chem. 2009 July 8-Epub ahead of print.", "ArticleIdList": ["PMC2782006", "19586906"]}, {"Citation": "Medoff BD, Landry AL, Wittbold KA, Sandall BP, Derby MC, Cao Z, Adams JC, Xavier RJ. CARMA3 mediates lysophosphatidic acid-stimulated cytokine secretion by bronchial epithelial cells. Am. J. Resp. Cell Mol. Biol. 40:286\u2013294.", "ArticleIdList": ["PMC2645526", "18757306"]}, {"Citation": "Szapacs ME, Kim HY, Porter NA, Liebler DC. Identification of proteins adducted by lipid peroxidation products in plasma and modifications of apolipoprotein A1 with a novel biotinylated phospholipid probe. J.Proteome.Res. 2008;7:4237\u20134246.", "ArticleIdList": ["PMC2664612", "18778096"]}, {"Citation": "Kuo CL, Raner GM, Vaz AD, Coon MJ. Discrete species of activated oxygen yield different cytochrome P450 heme adducts from aldehydes. Biochemistry. 1999;38:10511\u201310518.", "ArticleIdList": ["10441147"]}, {"Citation": "Guichardant M, Bernoud-Hubac N, Chantegrel B, Deshayes C, Lagarde M. Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids. Prostaglandins Leukot.Essent.Fatty Acids. 2002;67:147\u2013149.", "ArticleIdList": ["12324234"]}]}], "History": [{"Year": "2009", "Month": "11", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2009", "Month": "11", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "3", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "1", "Day": "18"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19916514", "NIHMS159723", "PMC2807911", "10.1021/tx900306p"]}}], "PubmedBookArticle": []}